Patent: 8,101,773
✉ Email this page to a colleague
Summary for Patent: 8,101,773
Title: | Hydroxy methyl phenyl pyrazolyl urea compounds useful in the treatment of cancer |
Abstract: | The compound 4-{4-[({3-tert-Butyl-1-[3-(hydroxymethyl)phenyl]-1H-pyrazol-5-yl}carbamoy- l)amino]-3-fluorophenoxy}-N-methylpyridine-2-carboxamide and alternative forms thereof (e.g., salts, solvates, hydrates, prodrugs, polymorphs and metabolites); pharmaceutical compositions which contain them; and methods for treating cancer using them. |
Inventor(s): | Smith; Roger (Chester Springs, PA), Nagarathnam; Dhanapalan (Bethany, CT) |
Assignee: | Bayer Healthcare LLC (Tarrytown, NY) |
Application Number: | 12/520,609 |
Patent Claims: | see list of patent claims |
Details for Patent 8,101,773
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Teknika Llc | TICE BCG | bcg live | For Injection | 102821 | 06/21/1989 | ⤷ Try a Trial | 2026-12-20 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2026-12-20 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2026-12-20 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |